| YouSigma- the web's most extensive resource for information |
|
|
|
|
Astrazeneca PLC (SWOT Analysis) |
“SWOT is an acronym for the internal Strengths and Weaknesses of a firm and the environmental Opportunities and Threats facing that firm. SWOT analysis is a widely used technique through which managers create a quick overview of a company’s strategic situation. The technique is based on the assumption that an effective strategy derives from a sound “fit” between a firm’s internal resources (strengths and weaknesses) and its external situation (opportunities and threats). A good fit maximizes a firm’s strengths and opportunities and minimizes its weaknesses and threats. Accurately applied, this simple assumption has powerful implications for the design of a successful strategy.”
Astrazeneca PLC
AstraZeneca is the second largest pharmaceutical company in the UK. The company was formed in 1999 by the merger of Swedish-based Astra and UK-based Zeneca Group. AstraZeneca has a strong presence in the US and retains a significant presence in Sweden as a legacy of Astra. The company is headquartered in London and employed about 65,000 people.
Strengths, Weaknesses, Opportunities and Threats (SWOT)
Location of Factor |
TYPE OF FACTOR |
|
Favorable |
Unfavorable |
|
Internal |
Strengths
|
Weaknesses
|
External |
Opportunities
|
Threats
|
| About YouSigma | Please Donate Using PayPal, to help us Develop Content | Copyright and Disclaimer |
|
Loading
|
|
|
"Astrazeneca PLC (SWOT Analysis)";